Jay R. Luly, President and CEO at ENANTA PHARMACEUTICALS INC (ENTA), sold 9,032 shares at $59.06 ($533K) on 2021-09-15, disclosed to the SEC on 2021-09-17.
Open-market sale of $533k ENTA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.06 | 4,516 | $267K | 50.0% |
| 2 | $59.06 | 4,516 | $267K | 50.0% |
| Total | $59.06 avg | 9,032 | $533K | 100% |
| Filing → |
| ENTA | SELL | 2024-12-10 | $41K | — | Filing → |
| ENTA | SELL | 2023-12-06 | $139K | — | Filing → |
| ENTA | SELL | 2023-03-14 | $2.5M | — | Filing → |